| Product Name | MF | CAS | Details |
|---|
| CTSL/CAPN1-IN-2 | C34H40N4O6 | 2410075-64-6 | Details |
| Divarasib adipate | 2762240-36-6 | Details |
| ChEs/MAOs-IN-2 | C15H12N2O3S | 693268-77-8 | Details |
| Antibacterial agent 172 | C21H21N9O5S2 | 3023114-93-1 | Details |
| Antifungal agent 100 | C23H21N3O4S | 2975157-18-5 | Details |
| BRD4 Inhibitor-30 | C28H38N6O4 | 1789731-20-9 | Details |
| DHX9-IN-5 | C23H24ClN5O4S | 2973398-17-1 | Details |
| CB7993113 | C15H10BrNO5 | 819827-50-4 | Details |
| ALR-38 | C19H17NO4 | 241127-61-7 | Details |
| Antiproliferative agent-22 | C17H13N3O3 | 1374305-45-9 | Details |
| Antibacterial agent 169 | 2879255-03-3 | Details |
| Anti-osteoporosis agent-3 | 2944463-16-3 | Details |
| CBR1-IN-7 | C22H22O13 | 1119826-35-5 | Details |
| CHI3L1-IN-1 | C22H27Cl2N3O | 2982256-78-8 | Details |
| CSF1R-IN-21 | C24H20F3N5O3 | 2935479-62-0 | Details |
| Atrazine-3-mercaptopropanoic acid | C11H19N5O2S | 125454-31-1 | Details |
| CVN766 | C20H21F3N8O | 1803557-42-7 | Details |
| BAY-155 | C28H28F3N7OS | 2163769-52-4 | Details |
| Antitumor agent-100 | C17H14ClN3O | 2841750-32-9 | Details |
| DNMT-IN-3 | C37H39N7O | 1683516-27-9 | Details |
| BChE-IN-23 | C20H19FN2O | 2020357-32-6 | Details |
| Akt1-IN-3 | C37H33N7O3 | 3033576-50-7 | Details |
| Antitumor agent-122 | 2378641-43-9 | Details |
| ATF4-IN-2 | C24H21BrClN5O4 | 2991057-60-2 | Details |
| DCLK1-IN-5 | C26H32ClN7O3S2 | 3028774-14-0 | Details |
| DHODH-IN-24 | C26H26N4 | 418775-30-1 | Details |
| CEP-28122 mesylate hydrochloride | C29H40Cl2N6O6S | 1354545-57-5 | Details |
| Aurora kinase inhibitor-11 | C11H10BrN3OS | 923946-98-9 | Details |
| CVM-05-002 | C16H14N4O3S2 | 2428738-43-4 | Details |
| Antidiabetic agent 5 | 2152667-21-3 | Details |
| BET-IN-20 | 1300735-76-5 | Details |
| Casein kinase 1δ-IN-15 | 2765264-27-3 | Details |
| CDK2-IN-18 | 364735-73-9 | Details |
| Antitumor agent-144 | C25H26N4O4 | 137346-42-0 | Details |
| CYP19A1/CYP11B2-IN-1 | C12H11N3O | 183500-36-9 | Details |
| ASN02563583 | C25H24N4O3S | 483283-39-2 | Details |
| BTK-IN-30 | C23H21F2N5O3 | 2662512-15-2 | Details |
| cGAS-IN-2 | C16H18Cl2N2O2 | 2765273-11-6 | Details |
| CSF1R-IN-20 | C25H26F3N5O3 | 2935479-57-3 | Details |
| ALDH1A1-IN-4 | C20H15ClN2 | 23982-86-7 | Details |
| CHI3L1-IN-2 | C26H37ClN4 | 2982257-63-4 | Details |
| CSF1R-IN-23 | C27H37N3O2 | 2935480-17-2 | Details |
| CVN293 | C14H10FN7O | 2815296-08-1 | Details |
| CSF1R-IN-22 | C20H20N6O3 | 2760585-35-9 | Details |
| CYP4A11/CYP4F2-IN-2 | 2280834-99-1 | Details |
| AS115 | C21H32FNO4 | 926657-43-4 | Details |
| CRT0066101 | C18H22N6O | 956123-34-5 | Details |
| C3TD879 | C22H28N4O | 2850259-33-3 | Details |
| DNMT/HDAC-IN-1 | 2095619-17-1 | Details |
| Antiangiogenic agent 5 | C25H22F3N5O3 | 2095397-52-5 | Details |
| AR/AR-V7-IN-1 | C36H43ClFN7O2 | 2964558-54-9 | Details |
| CDK8-IN-14 | C18H13N3O2 | 2924193-12-2 | Details |
| COX-1/2-IN-6 | 327024-84-0 | Details |
| DHODH-IN-25 | C22H19ClF5N3O5 | 2619531-95-0 | Details |
| DNA-PK-IN-12 | C21H24N8O2 | 2792146-91-7 | Details |
| ANO61 | C18H20N2O2 | 940476-20-0 | Details |
| Calcium mesoxalate | C6H6CaO12 | 21085-60-9 | Details |
| Anticancer agent 129 | C18H17N3 | 135882-37-0 | Details |
| Arfolitixorin sulfate | C20H25N7O10S | 149930-93-8 | Details |
| BAY-6096 | C21H23N6O2.Cl | 2313483-41-7 | Details |
| CXF-009 | C33H38N8O5 | 2727084-00-4 | Details |
| BTL-MK | C24H24O6 | 2758569-43-4 | Details |
| Anticancer agent 183 | 3018960-58-9 | Details |
| CCR8 antagonist 3 | C29H33N3O4 | 912463-57-1 | Details |
| DDABT1 | C40H34N4O4 | 2777045-35-7 | Details |
| COX-2-IN-40 | C19H11ClO3 | 444790-64-1 | Details |
| CZL80 | C19H14N2O4S | 313482-91-6 | Details |
| COX-2-IN-39 | C17H17N3O3S2 | 1018480-89-1 | Details |
| BChE-IN-25 | C17H23NO2 | 79183-25-8 | Details |
| BIO-7488 | C23H25N7O3 | 2573211-25-1 | Details |
| AQP3-IN-1 | C11H9AuCl2N2 | 198711-19-2 | Details |
| AR antagonist 5 | C23H21F3N6O2 | 2902679-53-0 | Details |
| BRD4 Inhibitor-29 | C21H28N2O3 | 902563-50-2 | Details |
| CXF-007 | C34H33N7O5 | 2727083-99-8 | Details |
| TM38837 | C27H20Cl2F3N7O | 1034264-77-1 | Details |
| Dopamine D4 receptor ligand 2 | C20H24ClN3O2 | 219125-63-0 | Details |
| CTPS1-IN-2 | C24H27N7O5S | 2377000-84-3 | Details |
| AMG-193 | C22H19F3N4O3 | 2790567-82-5 | Details |
| BAY-5516 | C23H17ClF4N2O3 | 2891706-79-7 | Details |
| Antifungal agent 87 | C14H14O4 | 692730-21-5 | Details |
| Anti-infective agent 9 | C14H11F3N4S2 | 758689-17-7 | Details |
| AQIM-I | C17H13N2O2.I | 2247881-73-6 | Details |
| Arginase inhibitor 7 | C14H29BN6O5 | 2377392-07-7 | Details |
| BaENR-IN-1 | C12H8ClNO4 | 1071966-17-0 | Details |
| CARM1-IN-4 | 2878481-07-1 | Details |
| CBR1-IN-4 | C17H13ClN2O3 | 1798284-64-6 | Details |
| CDK2-IN-27 | C18H21N7O2 | 2927473-94-5 | Details |
| c-Myc inhibitor 14 | C38H52BN3O7 | 2581994-88-7 | Details |
| COX-2-IN-43 | C18H11Cl2F3N2O3 | 1023524-40-4 | Details |
| CBR1-IN-5 | C17H13ClN2O3 | 1798284-62-4 | Details |
| DB18 | C24H18ClN7O3 | 2587177-94-2 | Details |
| Antitumor agent-138 | C20H21N3O4 | 2975168-22-8 | Details |
| BET-IN-23 | C29H34FN3O5 | 2953287-57-3 | Details |
| CBR1-IN-3 | C16H11ClN2O3 | 891101-69-2 | Details |
| Akt1-IN-4 | C37H31N7O3 | 3033577-05-5 | Details |
| ATAD2-IN-1 | C22H26N6O5 | 3004556-06-0 | Details |
| ATF4-IN-1 | C24H21Cl2N3O4 | 2991057-76-0 | Details |
| CD 10899 | C34H50N8O4 | 1331770-20-7 | Details |
| CDK2-IN-23 | C20H27F3N6O3S | 2488073-20-5 | Details |
| COX-1-IN-1 | C20H21NO3 | 1369503-03-6 | Details |
| Product Total： Product Page： | ||||
| 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 | ||||